—
C+
C+ The full Closelook — membership. Open the C+ overview

Kiniksa Pharmaceuticals Ltd (KNSA) — Technical state

As of 2026-09-22 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Uptrend stack intact

Trades +4.1% vs the 50-day and +42.2% vs the 200-day average, 6% below the 52-week high and +121.6% off the 52-week low. Computed from daily closes.

Ranked #10 on today’s Directional Flow — on a pullback list (scan of 2026-09-22).

The moving-average stack

Continue: the KNSA chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-09-22

Quick answers

What is the current Closelook signal on KNSA?

Uptrend stack intact — Trades +4.1% vs the 50-day and +42.2% vs the 200-day average, 6% below the 52-week high and +121.6% off the 52-week low. Computed from daily closes. As of 2026-09-22; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is KNSA above its 50-day and 200-day moving averages?

As of 2026-09-22, Kiniksa Pharmaceuticals Ltd trades +4.1% above its 50-day and +42.2% above its 200-day average, with the 20-day -0.2% away.

How far is KNSA from its 52-week high?

6% below the 52-week high and 121.6% above the 52-week low, as of 2026-09-22.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.